(Q34067607)

30 July 2017

1 reference

title

Genetics of familial and sporadic melanoma (English)

1 reference

30 July 2017

Bataille V

1

1 reference

30 July 2017

language of work or name

1 reference

1 September 2000

1 reference

Clinical and Experimental Dermatology

30 July 2017

published in

1 reference

30 July 2017

volume

25

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

464-470

1 reference

Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Germline p16 mutations in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Germline Mutations of the CDKN2 Gene in UK Melanoma Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

The genetics of hereditary melanoma and nevi. 1998 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Systemic cancer and the FAMMM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Melanoma genetics: an update with focus on the CDKN2A(p16)/ARF tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Mutation screening of the CDKN2A promoter in melanoma families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Mutation testing in melanoma families: INK4A, CDK4 and INK4D

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Retinoblastoma, melanoma and the atypical mole syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Second primary tumors in patients with retinoblastoma. A review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Five cases of coexistent primary ocular and cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Genetic predisposition to ocular melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Clonal heterogeneity in sporadic melanomas as revealed by loss-of-heterozygosity analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Development of a prostate cDNA microarray and statistical gene expression analysis package

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Prognostic significance of allelic losses in primary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

p16INK4a expression is frequently decreased and associated with 9p21 loss of heterozygosity in sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Genetics of risk factors for melanoma: an adult twin study of nevi and freckles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Sun exposure and melanocytic naevi in young Australian children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

The association between naevi and melanoma in populations with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Excess cancer mortality in six Dutch pedigrees with the familial atypical multiple mole-melanoma syndrome from 1830 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

CDKN2A Variants in a Population-Based Sample of Queensland Families With Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

An analysis of p16 protein expression in sporadic malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

Loss of heterozygosity in sporadic primary cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

CDKN2 explains part of the clinical phenotype in Dutch familial atypical multiple-mole melanoma (FAMMM) syndrome families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2230.2000.00689.X

10.1046/J.1365-2230.2000.00689.X

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference